Partner Therapeutics raises $60M, in-licenses Leukine

Newco Partner Therapeutics Inc. (Boston, Mass.) raised $60 million on Feb. 1 in a series A round led by Perceptive Advisors and also gained rights to Leukine sargramostim from Sanofi (Euronext:SAN; NYSE:SNY). Fellow new investors Adams St. Partners and MidCap Financial also participated in the round as did members of management.

The company, which launched on Jan. 25, plans to use this initial financing to acquire a cancer-focused portfolio of approved and late-stage therapies...